Thursday, Jan 8, 2026 · SEC filings
What the smart money revealed on Jan 8
378 insider filings came in. We hid 91 planned (10b5-1) sellers and 209 people whose filings were routine, like grants and tax withholding.
Surrozen (SRZN) Director Tim Kutzkey bought $300K
15,100 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 3 checked quarters beat the typical stock 6 months later.
Cosmos Health (COSM) CEO Grigorios Siokas bought $64.9K
124,880 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 7 checked quarters beat the typical stock 6 months later.
Broadcom (AVGO) President and CEO Hock Tan sold $24.3M
Not marked as a planned 10b5-1 sale. Sold 35% of the shares they held directly. Still holds 132,836 shares.
Broadcom (AVGO) Chief Legal & Corp Affairs Ofc Mark Brazeal sold $10.4M
Not marked as a planned 10b5-1 sale. Sold 12% of the shares they held directly. Still holds 210,573 shares.
Maze Therapeutics (MAZE) Director Catherine Sohn sold $1.15M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 7 more real buys
Show 47 more real sales
13F season
Holdings as of Dec 31, 2025 are due Feb 17
320 funds have filed so far. 81 filed for the quarter before.
Biggest real insider buys, Jan 2–8
Open-market buys by officers and directors, filed in the 7 days up to Jan 8.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.